Article

23,000 attend AAO, MEACO joint meeting

About 23,000 people attended this year?s American Academy of Ophthalmology (AAO) annual meeting in Chicago, according to the organization.

Chicago-About 23,000 people attended this year’s American Academy of Ophthalmology (AAO) annual meeting in Chicago, according to the organization.

The number represents a decrease from attendance at last year’s meeting in San Francisco, which was about 26,000, but an increase from 2007 and 2008, when attendance was about 22,000 for each meeting and the meetings were held in New Orleans and Atlanta, respectively, according to the AAO. The total includes domestic and international physicians, other health professionals, spouses, guests, and exhibitors.

This year’s annual meeting was held Oct. 16 to 19 in conjunction with the Middle East Africa Council of Ophthalmology (MEACO). It was the AAO’s first joint meeting with MEACO and the first time that a subspecialty day dedicated to oculofacial plastic surgery was held at the meeting.

The meeting included more than 500 instruction courses, 93 skills transfer courses, 165 breakfast-with-the-experts roundtables, 43 free symposia and spotlight sessions, and more than 2,000 scientific presentations.

“The meeting provides a tremendous opportunity for members from all over the world to gather and learn about the latest advances in ophthalmology,” said David W. Parke II, MD, the AAO’s chief executive officer. “The turnout was exceptional and the energy generated from the sessions was outstanding.”

The opening session for this year’s meeting featured addresses by Abdulaziz I. Alrajhi, MD, president of MEACO, and Douglas A. Jabs, MD, MBA, an expert in inflammatory eye disease who delivered the Jackson Memorial Lecture.  The opening session also included the presentation of the 2010 Laureate Recognition Award, the AAO’s highest honor, to Bradley R. Straatsma, MD, acclaimed as a pioneer in the study of peripheral retinal disease, investigations of tumors, and research on ophthalmic conditions such as diabetic retinopathy and cataract.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.